Deslorelin

Drug Profile

Deslorelin

Alternative Names: D-Trp-LHRH-PEA; LHRH agonist analogue; Somagard

Latest Information Update: 03 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nonindustrial source
  • Developer Nonindustrial source; Shire Pharmaceuticals Group
  • Class Antineoplastics; Hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Endometriosis; Polycystic ovary syndrome; Precocious puberty; Prostate cancer; Uterine leiomyoma

Most Recent Events

  • 10 Mar 2003 A study has been added to the Endocrine disorders therapeutic trials section
  • 15 Feb 2001 Discontinued-III for Prostate cancer in Europe (IV-injection)
  • 22 Jun 2000 Discontinued-Clinical for Polycystic ovary syndrome in USA (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top